Literature DB >> 11165779

Detection of the presenilin 1 gene mutation (M139T) in early-onset familial Alzheimer disease in Spain.

R Queralt1, M Ezquerra, M Castellví, A Lleó, R Blesa, R Oliva.   

Abstract

In a family with early-onset Alzheimer disease (EOAD) from Spain we found a mutation in the presenilin 1 (PS1) gene that predicts a methionine-to-threonine change at the PS1 residue 139 (M139T). This mutation was previously reported in a independent French family. The age of onset of the disease was similar in the affected members from both families, suggesting a specific age of expression (range 47-50 years). The detection of the M139T mutation in an independent EOAD family strongly supports the pathogenicity of this mutation in familial Alzheimer disease (AD).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165779     DOI: 10.1016/s0304-3940(01)01498-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Presenilin 1 gene mutation (M139I) in a patient with an early-onset Alzheimer's disease: clinical characteristics and genetic identification.

Authors:  Hee-Jin Kim; Hyun Young Kim; Chang-Seok Ki; Seung Hyun Kim
Journal:  Neurol Sci       Date:  2010-03-06       Impact factor: 3.307

Review 2.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

3.  Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort.

Authors:  Sheng Chih Jin; Pau Pastor; Breanna Cooper; Sebastian Cervantes; Bruno A Benitez; Cristina Razquin; Alison Goate; Carlos Cruchaga
Journal:  Alzheimers Res Ther       Date:  2012-08-20       Impact factor: 6.982

Review 4.  An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer's Disease.

Authors:  Chantal Vidal; Li Zhang
Journal:  Cells       Date:  2021-03-04       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.